HMGA2 and cancer: In contrast to the oncogenic function of miR-150-5p in NSCLC cells, miR-150-5p was significantly downregulated in cancer stem cells in NSCLC [39], and the expression of miR-150-5p was demonstrated to inhibit the HMGA2 and β-catenin signaling pathways [39].